Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer.
Kasperlik-Załuska
A A
AA
Migdalska
B
B
Makowska
A
A
D000293:Adolescent; D000306:Adrenal Cortex Neoplasms / Q000401:mortality / Q000628:therapy*; D000328:Adult; D000368:Aged; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008939:Mitotane / Q000627:therapeutic use*; D015996:Survival Rate
D008939:Mitotane